Megapime XP 1000 mg/125 mg Injection
By Megapime XP
Rx
2ml Injection in a Vial

Composition
Cefepime(1000mg) + Tazobactum(125mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
October, 2025

liver
Megapime XP 1000 mg/125 mg Injection is considered safe for use in patients with liver disease based on the available information. Limited data indicates that adjusting the dosage of Megapime XP 1000 mg/125 mg Injection may not be necessary for individuals with liver issues. However, it is important to consult with your doctor before using this medication to ensure the appropriate safety measures are in place.

kidney
Megapime XP 1000 mg/125 mg Injection should be used carefully in patients with kidney problems. Adjusting the dosage of Megapime XP 1000 mg/125 mg Injection may be necessary. Consult your doctor for guidance on its use.

alcohol
When using Megapime XP 1000 mg/125 mg Injection, caution is advised while consuming alcohol. It is recommended to consult your doctor regarding alcohol consumption with this medication.

driving
When using Megapime XP 1000 mg/125 mg Injection, be cautious as it may temporarily blur your vision. Avoid driving until your vision is fully clear.

pregnancy
Megapime XP 1000 mg/125 mg Injection is usually safe to use during pregnancy. Animal studies suggest minimal risks to the baby, but human studies are limited.

breastfeeding
Megapime XP 1000 mg/125 mg Injection is considered safe for breastfeeding as research shows minimal transfer into breastmilk, posing no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹218
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025